Economy/Home · Economy

JW Pharmaceutical Launches 'Frenz EyeCrunch'… Stock Rises for Second Straight Session, Up 2.37% to 28,050 Won

JW Pharmaceutical's share price is showing strength as the company moves to expand the product lineup of its eye care brand 'Frenz.' On the afternoon of the 31st, JW Pharmaceutical's stock was trading at 28,050 won, up 650 won (2.37%) from the previous trading day. The share price has advanced for

Wooil Shim
Staff Reporter
4 min read
JW Pharmaceutical Launches 'Frenz EyeCrunch'… Stock Rises for Second Straight Session, Up 2.37% to 28,050 Won
CBC News

JW Pharmaceutical's share price is showing strength as the company moves to expand the product lineup of its eye care brand 'Frenz.'

On the afternoon of the 31st, JW Pharmaceutical's stock was trading at 28,050 won, up 650 won (2.37%) from the previous trading day. The share price has advanced for two consecutive sessions, continuing its upward trend.

■ Launch of Chewable Eye Care Candy 'EyeCrunch'

JW Pharmaceutical announced that it launched 'EyeCrunch,' a chewable candy, on this day as the first expanded new product featuring the integrated brand identity (BI) of Frenz.

This product is notable for expanding the Frenz brand, which had been developed mainly around existing eye care products, into a new product category. The company applied its newly unified integrated BI to strengthen brand consistency, and the product was developed in a candy form that can be easily chewed.

Starting with this new product, JW Pharmaceutical plans to broaden the product portfolio of the Frenz brand to expand consumer touchpoints.

■ Stock Rise Cannot Be Attributed Solely to New Product Launch

However, it is difficult to conclude that the day's stock increase was driven solely by the new product launch. Individual stock prices can be influenced by a combination of factors, including market supply and demand, trends in the pharmaceutical and biotech sector, and corporate performance and business outlook.

[※ This article was written for the purpose of providing information on the stock market and companies. It does not recommend the purchase or sale of specific stocks or guarantee investment returns. Investment decisions and responsibilities rest with the investor. Stock prices may fluctuate during trading hours. This article was written with AI assistance.]

Wooil Shim
Staff Reporter

CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.